Analyzing Big Picture for Intersect ENT, Inc. (NASDAQ: XENT)

Health and Biotech

On 22 Nov 2019, Intersect ENT, Inc. (NASDAQ: XENT) stock observed trading -40.81% off 52-week high price. On the other end, the stock has been noted 45.26% away from low price over the last 52-weeks. The stock disclosed a move of 13.99% away from 50 day moving average and -10.43% away from 200 day moving average. Moving closer, we can see that shares have been trading 3.71% off 20-day moving average. It has market cap of $673.42M.

Intersect ENT, Inc. (XENT) recently stated financial results for the third quarter ended September 30, 2019.

Total revenue was $24.1M for the third quarter of 2019 contrast to $24.7M for the same period of 2018. This decrease resulted from lower unit sales of the PROPEL® family of products, partially offset by the growth in adoption of SINUVA®, which contributed $1.1M, or 5% of third quarter 2019 revenue.

Gross profit for the third quarter was $19.2M and gross margin was 80%, contrast to gross profit of $19.5M and gross margin of 79% for the same period of 2018.

Operating expenses for the third quarter of 2019 were $32.6M, contrast to $27.6M in the same period of 2018, a raise of 18%. R&D expenses increased to $6.1M from $4.9M, primarily Because of expenses related to the company’s investigational ASCEND drug-coated sinus balloon and a raise in personnel-related expenses. SG&A expenses increased to $26.4M from $22.8M, primarily Because of the expansion of SINUVA commercial and market access activities, including headcount, marketing and consulting expenses, and the incremental stock-based compensation associated with the leadership change.

The USA based company Intersect ENT, Inc. moved with change of -0.56% to $21.23 with the total traded volume of 257067 shares in recent session versus to an average volume of 387.47K. The stock was observed in the 5 days activity at 0.24%. The one month performance of stock was 19.64%. XENT’s shares are at 34.62% for the quarter and driving a -27.17% return over the course of the past year and is now at -24.66% since this point in 2018.  Right now the stock beta is 0.76. The average volatility for the week and month was at 2.42% and 4.06% respectively. There are 31.72M shares outstanding and 30.49M shares are floated in market.